Volume 27, Issue 149 (6-2017)                   J Mazandaran Univ Med Sci 2017, 27(149): 187-191 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fouladvand M, Barazesh A, Tahmasebi R. Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012. J Mazandaran Univ Med Sci. 2017; 27 (149) :187-191
URL: http://jmums.mazums.ac.ir/article-1-8651-en.html
Abstract:   (3789 Views)

Background and purpose: Strongyloidiasis is a nematode infection of humans with a worldwide distribution which is more prevalent in tropical and subtropical regions. Infected people are often clinically asymptomatic, however, in untreated immunosuppressed patients, it causes more than 80% mortality. So, the accurate and timely diagnosis of infection can prevent patient's death. This study was conducted to determine the prevalence of strongyloidiasis in patients under chemotherapy and hemodialysis in Bushehr, Iran.

Materials and methods: We performed a cross-sectional study in 2011-2012 in which all chemotherapy and hemodialysis patients were evaluated by ELISA method to determine the presence of anti-Strongyloides stercoralis IgG antibody.

Results: A total of 214 individuals were studied from whom 4 (1.9%) patients under chemotherapy and 3 (1.4%) hemodialysis patients were positive for IgG antibody.

Conclusion: Strongyloidiasis is as a life-threatening risk factor in people under chemotherapy and hemodialysis, therefore, strongyloidiasis screening is suggested in these patients before administering immunosuppressive drugs, dialysis, and kidney transplant.

Full-Text [PDF 210 kb]   (839 Downloads)    
Type of Study: Brief Report | Subject: parasitology

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb